Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
NRx Pharmaceuticals, Inc. (NRXP) had Return on Assets of 2.79% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.98M |
|
$0.36M |
|
$0.41M |
|
$0.57M |
|
$5.61M |
|
$-4.62M |
|
$4.99M |
|
$0.36M |
|
$0.40M |
|
$0.36M |
|
$0.36M |
|
$0.36M |
|
$0.40M |
|
$-4.62M |
|
$-4.52M |
|
21.40M |
|
21.40M |
|
$0.25 |
|
$0.25 |
|
| Balance Sheet Financials | |
$8.89M |
|
$0.06M |
|
$4.06M |
|
$12.96M |
|
$28.58M |
|
-- |
|
$0.32M |
|
$28.89M |
|
$-15.94M |
|
$-18.66M |
|
$-15.94M |
|
31.73M |
|
| Cash Flow Statement Financials | |
$-14.11M |
|
$-2.81M |
|
$23.28M |
|
$1.44M |
|
$7.80M |
|
$6.35M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
58.49% |
|
-470.29% |
|
-470.29% |
|
-- |
|
36.72% |
|
36.72% |
|
$-14.11M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
6.11 |
|
14.74 |
|
-2.27% |
|
-1.94% |
|
|
Return on Assets |
2.79% |
-2.27% |
|
$-0.50 |
|
$-0.66 |
|
$-0.66 |
|